Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Arthur Allen | (TNS) KFF Health News When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug … Continued